| INE | infantile necrotizing encephalomyelopathy |
|---|
| SNE | Subacute necrotizing encephalomyelopathy |
|---|
| carcinomatous encephalomyelopathy | An encephalomyelopathy as a remote effect of carcinoma, most often oat cell carcinoma of the lung; characterised by extensive nerve cell loss, which may be diffuse, but often predominates in particular portions of the central nervous system, particularly the limbic lobes, medulla, cerebellum, and gray matter of the spinal cord. Synonym: carcinomatous encephalomyelopathy, encephalomyelitis associated with carcinoma, paracarcinomatous encephalomyelopathy. (05 Mar 2000) |
|---|
| carcinomatous | Pertaining to or manifesting the characteristic properties of carcinoma. (05 Mar 2000) |
|---|---|
| carcinomatous implants | Transference of carcinoma cells from a primary tumour to adjacent tissues where growth continues. (05 Mar 2000) |
| carcinomatous myelopathy | Degeneration or necrosis of the spinal cord associated with a carcinoma. Synonym: paracarcinomatous myelopathy. (05 Mar 2000) |
| carcinomatous myopathy | <syndrome> A condition characterised by muscle weakness that is similar to the symptoms of myasthenia gravis. For this reason, it has been referred to as myasthenic syndrome. This disorder is caused by an insufficient release of neurotransmitter (acetylcholine) by the nerve cells. Unlike myasthenia gravis, as muscle contractions are continued, strength will increase. The cause of Lambert-Eaton syndrome is unknown, but is usually associated with small cell carcinoma of the lung or an autoimmune illness. (27 Sep 1997) |
| carcinomatous neuromyopathy | Neuromyopathy associated with carcinoma, especially of the lung. (05 Mar 2000) |
| carcinomatous pericarditis | Pericarditis due to infiltration of carcinomatous cells, usually from surrounding structures. (05 Mar 2000) |
| paracarcinomatous encephalomyelopathy | An encephalomyelopathy as a remote effect of carcinoma, most often oat cell carcinoma of the lung; characterised by extensive nerve cell loss, which may be diffuse, but often predominates in particular portions of the central nervous system, particularly the limbic lobes, medulla, cerebellum, and gray matter of the spinal cord. Synonym: carcinomatous encephalomyelopathy, encephalomyelitis associated with carcinoma, paracarcinomatous encephalomyelopathy. (05 Mar 2000) |
| paraneoplastic encephalomyelopathy | An encephalomyelopathy as a remote effect of carcinoma, most often oat cell carcinoma of the lung; characterised by extensive nerve cell loss, which may be diffuse, but often predominates in particular portions of the central nervous system, particularly the limbic lobes, medulla, cerebellum, and gray matter of the spinal cord. Synonym: carcinomatous encephalomyelopathy, encephalomyelitis associated with carcinoma, paracarcinomatous encephalomyelopathy. (05 Mar 2000) |
| necrotizing encephalomyelopathy | Subacute encephalomyelopathy affecting infants, causing dementia, spasticity, and optic atrophy; autosomal recessive inheritance. Synonym: necrotizing encephalomyelopathy, necrotizing encephalopathy. (05 Mar 2000) |
| subacute necrotizing encephalomyelopathy | A rare fatal disorder, primarily of children, being both acute and chronic in onset, manifested primarily as brainstem dysfunction, with ataxia, cranial nerve palsies, pseudobulbar palsy, hemi-or quadriplegia, mental deterioration, and involuntary movements; deficiencies of pyruvate dehydrogenase or cytochrome C oxydase have been found in some patients; pathologically, there is widespread symmetric necrosis involving much of the brainstem; these changes are similar to those seen with Wernicke encephalopathy. (05 Mar 2000) |
| encephalomyelopathy | Any disease of both brain and spinal cord. Origin: G. Enkephalos, brain, + myelon, marrow, + pathos, suffering (05 Mar 2000) |
| epidemic myalgic encephalomyelopathy | A disease superficially resembling poliomyelitis, characterised by diffuse involvement of the nervous system associated with myalgia. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|